Maintaining its Leadership in the Middle East and North Africa RIYADH, Saudi Arabia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- In an ...
3 天
News Medical on MSNVancomycin could offer new therapeutic option for patients with a type of inflammatory ...An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.
Researchers from the HUN-REN Biological Research Centre, Szeged (Hungary), have ... they will remain effective in the long run in clinical use." The studies found that resistance developed rapidly ...
Since 1998, we have delivered innovative simulation-based education to healthcare students and professionals. We have evolved with changes in clinical practice and technology. We have expanded to ...
Patients across GM and the UK, will have greater access to cutting-edge treatments and clinical trials following a government announcement of £100m of private investment to set up local research hubs.
A clinical trial involves the study of the safety, efficacy and/or dosage regimen of a therapeutic intervention (such as a drug) in humans selected according to predetermined criteria of ...
We acknowledge the land on which Brock University was built is the traditional territory of the Haudenosaunee and Anishinaabe people, many of whom continue to live and work here today. This territory ...
The Wolfson Centre for Young People’s Mental Health's clinical seminar series was launched in the summer of 2022. Each virtual talk lasts for an hour, including a Q&A session with the guest speaker.
World-leading international research centre in the field of ESSENCE (neurodevelopmental disorders ... neuropsychiatry and developmental neurology ("ESSENCE", i.e. Early Symptomatic Syndromes Eliciting ...
The Company will be focusing on the following programs with Bucillamine: Revive is targeting nerve agent exposure as its initial indication for its medical countermeasures program. Nerve agents are ...
Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses vs.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果